<p>Revvity Inc.（纽约证券交易所代码：RVTY - 获取免费报告）在目前覆盖该股票的十四位分析师中获得了 “适度买入” 的共识评级，MarketBeat.com 报道称。一位投资分析师给予该股票卖出评级，五位分析师给予持有评级，八位分析师给予买入评级。在过去一年中更新了对该股票覆盖的分析师中，平均一年目标价为 114.75 美元。</p>
<p>RVTY 最近成为多份研究报告的主题。巴克莱在 10 月 28 日的报告中将 Revvity 的目标价从 100.00 美元上调至 105.00 美元，并给予公司 “增持” 评级。古根海姆在 10 月 15 日的研究报告中开始覆盖 Revvity 的股票，并为公司设定了 “中性” 评级。Evercore ISI 在 10 月 27 日的研究报告中重申了 “跑赢大盘” 评级，并对 Revvity 的股票设定了 108.00 美元的目标价。罗伯特·W·贝尔德在 10 月 28 日的报告中将 Revvity 的目标价从 122.00 美元上调至 123.00 美元，并给予该股票 “跑赢大盘” 评级。最后，美国银行在 9 月 22 日的研究报告中将 Revvity 的目标价从 110.00 美元下调至 99.00 美元，并对该股票设定了 “买入” 评级。</p>
<p><strong>阅读我们关于 Revvity 的最新研究报告</strong></p>
<h2>对 Revvity 的对冲基金看法</h2>
<p>大型投资者最近增加或减少了对公司的持股。T. Rowe Price Investment Management Inc.在第一季度将其在 Revvity 的股份增加了 8.5%。T. Rowe Price Investment Management Inc.目前拥有 22,515,711 股公司股票，价值 2,382,163,000 美元，在上一季度购买了额外的 1,754,403 股。先锋集团在第一季度将其在 Revvity 的持股增加了 0.6%。先锋集团目前拥有 14,382,849 股公司股票，价值 1,521,705,000 美元，在此期间购买了额外的 92,638 股。Price T Rowe Associates Inc. MD 在第一季度将其在 Revvity 的持股增加了 25.3%。Price T Rowe Associates Inc. MD 目前拥有 9,563,911 股公司股票，价值 1,011,863,000 美元，在此期间购买了额外的 1,932,314 股。EdgePoint Investment Group Inc.在第三季度将其在 Revvity 的股份增加了 26.3%。EdgePoint Investment Group Inc.目前拥有 8,574,280 股公司股票，价值 751,536,000 美元，在上一季度购买了额外的 1,784,620 股。最后，景顺有限公司在第三季度将其在 Revvity 的持股增加了 15.7%。景顺有限公司目前拥有 2,553,515 股公司股票，价值 223,816,000 美元，在此期间获得了额外的 346,313 股。对冲基金和其他机构投资者拥有公司 86.65% 的股票。</p>
<h2>Revvity 股票下跌 1.7%</h2>
<p>RVTY 股票在周五开盘价为 100.81 美元。该公司的市值为 114.3 亿美元，市盈率为 50.66，市盈增长比率为 3.39，贝塔值为 1.06。该公司的债务与股本比率为 0.36，速动比率为 1.44，流动比率为 1.75。该公司的 50 日移动平均线为 95.01 美元，200 日移动平均线为 92.97 美元。Revvity 的 52 周低点为 81.36 美元，52 周高点为 128.29 美元。</p>
<p>Revvity（纽约证券交易所代码：RVTY - 获取免费报告）在 10 月 27 日发布了季度财报。该公司报告季度每股收益为 1.18 美元，超出共识预期的 1.14 美元，超出幅度为 0.04 美元。Revvity 的净利润率为 8.44%，股本回报率为 7.52%。该公司在本季度的收入为 6.9895 亿美元，而分析师预期为 6.9975 亿美元。去年同期，该公司的每股收益为 1.28 美元。与去年同期相比，该公司的季度收入增长了 2.2%。Revvity 已将其 2025 财年的指导目标设定为 4.900-5.000 美元每股收益。整体来看，分析师预测 Revvity 在当前年度的每股收益为 4.94 美元。</p>
<h2>Revvity 宣布分红</h2>
<p>该公司还最近披露了季度分红，将于 2 月 6 日（星期五）支付。1 月 16 日（星期五）的登记投资者将获得每股 0.07 美元的分红。除息日期为 1 月 16 日（星期五）。这代表着年化分红为 0.28 美元，分红收益率为 0.3%。Revvity 的派息比率为 14.07%。</p>
<p>Revvity 宣布其董事会在 10 月 27 日启动了一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8.7% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>Revvity 公司简介</h2>
<p>（获取免费报告）</p>
<p>Revvity, Inc 在美洲、欧洲和亚洲及国际上提供健康科学解决方案、技术和服务。生命科学部门提供仪器、试剂、信息学、软件、订阅、检测、成像技术、保修、培训和服务。其诊断部门提供仪器、试剂、检测平台和软件产品，用于早期检测遗传疾病，如妊娠和早期儿童疾病，以及诊断市场中的传染病检测。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 Revvity 更好</li>
<li>上升趋势股票解释：学习如何利用上升趋势进行交易</li>
<li>火箭实验室的大反弹？分析师建议抄底</li>
<li>为什么投资 5G？如何投资 5G 股票</li>
<li>Meta 的人工智能时刻？新的 SAM 3 模型让华尔街转向看涨</li>
<li>最具波动性的股票，投资者需要知道的</li>
<li>Snowflake 股票：聪明投资者现在正在购买的下跌</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Revvity 吗？</h2>
<p>在考虑 Revvity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Revvity 并不在名单上。</p>
<p>虽然 Revvity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

RVTY

<p>Revvity Inc.（纽约证券交易所代码：RVTY）获得 14 位分析师的共识 “适度买入” 评级，平均目标价为 114.75 美元。最近的分析师行动包括巴克莱将目标价上调至 105 美元，罗伯特·W·贝尔德上调至 123 美元。该股票开盘价为 100.81 美元，市值为 114.3 亿美元。Revvity 报告第三季度每股收益为 1.18 美元，超出预期。公司宣布了一项 10 亿美元的股票回购计划</p>

<p>Revvity Inc. (NYSE:RVTY - Get Free Report) has earned a consensus rating of &#34;Moderate Buy&#34; from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $114.75.</p>
<div class="lb-trans"><p>Revvity Inc.（纽约证券交易所代码：RVTY - 获取免费报告）在目前覆盖该股票的十四位分析师中获得了 “适度买入” 的共识评级，MarketBeat.com 报道称。一位投资分析师给予该股票卖出评级，五位分析师给予持有评级，八位分析师给予买入评级。在过去一年中更新了对该股票覆盖的分析师中，平均一年目标价为 114.75 美元。</p>
</div><p>RVTY has been the subject of a number of research reports. Barclays upped their target price on shares of Revvity from $100.00 to $105.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 28th. Guggenheim started coverage on shares of Revvity in a research report on Wednesday, October 15th. They set a &#34;neutral&#34; rating for the company. Evercore ISI restated an &#34;outperform&#34; rating and issued a $108.00 price objective on shares of Revvity in a research note on Monday, October 27th. Robert W. Baird raised their target price on Revvity from $122.00 to $123.00 and gave the stock an &#34;outperform&#34; rating in a report on Tuesday, October 28th. Finally, Bank of America lowered their target price on Revvity from $110.00 to $99.00 and set a &#34;buy&#34; rating on the stock in a research report on Monday, September 22nd.</p>
<div class="lb-trans"><p>RVTY 最近成为多份研究报告的主题。巴克莱在 10 月 28 日的报告中将 Revvity 的目标价从 100.00 美元上调至 105.00 美元，并给予公司 “增持” 评级。古根海姆在 10 月 15 日的研究报告中开始覆盖 Revvity 的股票，并为公司设定了 “中性” 评级。Evercore ISI 在 10 月 27 日的研究报告中重申了 “跑赢大盘” 评级，并对 Revvity 的股票设定了 108.00 美元的目标价。罗伯特·W·贝尔德在 10 月 28 日的报告中将 Revvity 的目标价从 122.00 美元上调至 123.00 美元，并给予该股票 “跑赢大盘” 评级。最后，美国银行在 9 月 22 日的研究报告中将 Revvity 的目标价从 110.00 美元下调至 99.00 美元，并对该股票设定了 “买入” 评级。</p>
</div><p><strong>Read Our Latest Research Report on Revvity</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Revvity 的最新研究报告</strong></p>
</div><h2>Hedge Funds Weigh In On Revvity</h2>
<div class="lb-trans"><h2>对 Revvity 的对冲基金看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its stake in shares of Revvity by 8.5% in the first quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock worth $2,382,163,000 after purchasing an additional 1,754,403 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock worth $1,521,705,000 after buying an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Revvity by 25.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after buying an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. increased its stake in Revvity by 26.3% in the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock worth $751,536,000 after buying an additional 1,784,620 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Revvity by 15.7% during the third quarter. Invesco Ltd. now owns 2,553,515 shares of the company's stock valued at $223,816,000 after acquiring an additional 346,313 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近增加或减少了对公司的持股。T. Rowe Price Investment Management Inc.在第一季度将其在 Revvity 的股份增加了 8.5%。T. Rowe Price Investment Management Inc.目前拥有 22,515,711 股公司股票，价值 2,382,163,000 美元，在上一季度购买了额外的 1,754,403 股。先锋集团在第一季度将其在 Revvity 的持股增加了 0.6%。先锋集团目前拥有 14,382,849 股公司股票，价值 1,521,705,000 美元，在此期间购买了额外的 92,638 股。Price T Rowe Associates Inc. MD 在第一季度将其在 Revvity 的持股增加了 25.3%。Price T Rowe Associates Inc. MD 目前拥有 9,563,911 股公司股票，价值 1,011,863,000 美元，在此期间购买了额外的 1,932,314 股。EdgePoint Investment Group Inc.在第三季度将其在 Revvity 的股份增加了 26.3%。EdgePoint Investment Group Inc.目前拥有 8,574,280 股公司股票，价值 751,536,000 美元，在上一季度购买了额外的 1,784,620 股。最后，景顺有限公司在第三季度将其在 Revvity 的持股增加了 15.7%。景顺有限公司目前拥有 2,553,515 股公司股票，价值 223,816,000 美元，在此期间获得了额外的 346,313 股。对冲基金和其他机构投资者拥有公司 86.65% 的股票。</p>
</div><h2>Revvity Stock Down 1.7%</h2>
<div class="lb-trans"><h2>Revvity 股票下跌 1.7%</h2>
</div><p>RVTY stock opened at $100.81 on Friday. The company has a market cap of $11.43 billion, a price-to-earnings ratio of 50.66, a P/E/G ratio of 3.39 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.75. The business's 50-day moving average is $95.01 and its two-hundred day moving average is $92.97. Revvity has a fifty-two week low of $81.36 and a fifty-two week high of $128.29.</p>
<div class="lb-trans"><p>RVTY 股票在周五开盘价为 100.81 美元。该公司的市值为 114.3 亿美元，市盈率为 50.66，市盈增长比率为 3.39，贝塔值为 1.06。该公司的债务与股本比率为 0.36，速动比率为 1.44，流动比率为 1.75。该公司的 50 日移动平均线为 95.01 美元，200 日移动平均线为 92.97 美元。Revvity 的 52 周低点为 81.36 美元，52 周高点为 128.29 美元。</p>
</div><p>Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The firm had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the prior year, the firm earned $1.28 EPS. The business's revenue for the quarter was up 2.2% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. As a group, analysts forecast that Revvity will post 4.94 earnings per share for the current year.</p>
<div class="lb-trans"><p>Revvity（纽约证券交易所代码：RVTY - 获取免费报告）在 10 月 27 日发布了季度财报。该公司报告季度每股收益为 1.18 美元，超出共识预期的 1.14 美元，超出幅度为 0.04 美元。Revvity 的净利润率为 8.44%，股本回报率为 7.52%。该公司在本季度的收入为 6.9895 亿美元，而分析师预期为 6.9975 亿美元。去年同期，该公司的每股收益为 1.28 美元。与去年同期相比，该公司的季度收入增长了 2.2%。Revvity 已将其 2025 财年的指导目标设定为 4.900-5.000 美元每股收益。整体来看，分析师预测 Revvity 在当前年度的每股收益为 4.94 美元。</p>
</div><h2>Revvity Announces Dividend</h2>
<div class="lb-trans"><h2>Revvity 宣布分红</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity's payout ratio is 14.07%.</p>
<div class="lb-trans"><p>该公司还最近披露了季度分红，将于 2 月 6 日（星期五）支付。1 月 16 日（星期五）的登记投资者将获得每股 0.07 美元的分红。除息日期为 1 月 16 日（星期五）。这代表着年化分红为 0.28 美元，分红收益率为 0.3%。Revvity 的派息比率为 14.07%。</p>
</div><p>Revvity announced that its board has initiated a stock buyback program on Monday, October 27th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to purchase up to 8.7% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Revvity 宣布其董事会在 10 月 27 日启动了一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8.7% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Revvity Company Profile</h2>
<div class="lb-trans"><h2>Revvity 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.</p>
<div class="lb-trans"><p>Revvity, Inc 在美洲、欧洲和亚洲及国际上提供健康科学解决方案、技术和服务。生命科学部门提供仪器、试剂、信息学、软件、订阅、检测、成像技术、保修、培训和服务。其诊断部门提供仪器、试剂、检测平台和软件产品，用于早期检测遗传疾病，如妊娠和早期儿童疾病，以及诊断市场中的传染病检测。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Revvity</li>
<li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li>
<li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li>
<li>Why Invest in 5G? How to Invest in 5G Stocks</li>
<li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li>
<li>Most Volatile Stocks, What Investors Need to Know</li>
<li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Revvity 更好</li>
<li>上升趋势股票解释：学习如何利用上升趋势进行交易</li>
<li>火箭实验室的大反弹？分析师建议抄底</li>
<li>为什么投资 5G？如何投资 5G 股票</li>
<li>Meta 的人工智能时刻？新的 SAM 3 模型让华尔街转向看涨</li>
<li>最具波动性的股票，投资者需要知道的</li>
<li>Snowflake 股票：聪明投资者现在正在购买的下跌</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=RVTY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Revvity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Revvity 吗？</h2>
</div><p>Before you consider Revvity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Revvity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Revvity 并不在名单上。</p>
</div><p>While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Revvity 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Revvity 公司（NYSE 代码：RVTY）被分析师一致评为 “适度买入”